FDA Approves First Generic Infuvite Adult Injection

The U.S. Food and Drug Administration has approved the initial generic versions of Infuvite Adult Injection, developed by Apotex Corp. in partnership with Orbicular and Gland Pharma. This approval encompasses both single-dose and pharmacy bulk packages of the medication. The pharmacy bulk package also qualifies for 180-day competitive generic therapy exclusivity, which could impact patients requiring parenteral nutrition.